Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Meshach G. Kirubakaran"'
Autor:
Michael D Hughson, John P. Dowling, John F. Bertram, Susan A. Mott, Agnes B. Fogo, Terence Samuel, Priscilla Kincaid-Smith, Wendy E. Hoy, Rebecca N. Douglas-Denton, Rajalingam Sinniah, Meshach G. Kirubakaran, David J Pugsley
Publikováno v:
Kidney international. 82(12)
Australia's Indigenous people have high rates of chronic kidney disease and kidney failure. To define renal disease among these people, we reviewed 643 renal biopsies on Indigenous people across Australia, and compared them with 249 biopsies of non-I
Autor:
Isthiaque, Ahmed, George T, John, Meshach G, Kirubakaran, Chakko K, Jacob, Jayaprakash, Muliyil
Publikováno v:
The Indian journal of medical research. 124(2)
Presence of proteinuria is considered as an early marker of an increased risk of progressive kidney disease. Angiotensin converting enzyme (ACE) inhibitors (ACEi) and angiotensin II receptor blockers (ARB) treatment to persons with proteinuria and ch
Autor:
Balakrishnan, Narasimhan, Bobby, Chacko, George T, John, Anila, Korula, Meshach G, Kirubakaran, Chakko K, Jacob
Publikováno v:
Journal of nephrology. 19(2)
In the absence of a renal biopsy registry, there is a paucity of data on the renal disease pattern seen in India. This study reviews the changing pattern of renal disease seen at a single center over the last 30 yrs.Histopathological data of 5415 ade
Autor:
Sundaram, Madhivanan, George T, John, Thirugnanam, Rajasekar, Sheila, Nair, Meshach G, Kirubakaran, Chakko Korula, Jacob
Publikováno v:
The National medical journal of India. 19(1)
Publikováno v:
Renal failure. 27(3)
Despite significant improvements in medical care, acute renal failure (ARF) remains a high risk for mortality. It is important to be able to predict the outcome in these patients in view of the emotional and ethical needs of the patients and to addre
Autor:
William Blessing, Richard Burns, Meshach G Kirubakaran, Peter B Lindschau, Nadarajah Rajabalendaran, Lindsay Mollison
Publikováno v:
Medical Journal of Australia. 159:28-29
OBJECTIVE To present the first documented case of human T-lymphotropic virus type I (HTLV-I) associated myelopathy/tropical spastic paraparesis in the Australian population. CLINICAL FEATURES A 31-year-old Aboriginal man with an 18-month history of p
Autor:
J. C. M. Shastry, Ganesh Gopalakrishnan, Meshach G. Kirubakaran, P. P. Thomas, C. K. Jacob, A. P. Pandey
Publikováno v:
Transplantation. 48:155
Toutes les greffes rejetees ne doivent pas etre enlevees avant la retransplantation. L'immunodepression peut etre progressivement reduite et arretee en cas d'indication chez certains malades sans effets nefastes sur la greffe rejetee ou sur les greff